Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Grantham

Showing results (191-200 of 230) with videos related to

Pageof 23
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 19, 2015
Albuminuria and tolvaptan in autosomal-dominant polycystic kidney disease: results of the TEMPO 3:4 TrialRon T Gansevoort, Esther Meijer, Arlene B Chapman, et al.
Environmental Science & Technology|March 5, 2010
Feather lead concentrations and (207)Pb/(206)Pb ratios reveal lead exposure history of California Condors (Gymnogyps californianus)M E Finkelstein, D George, S Scherbinski, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 19, 2016
Tolvaptan suppresses monocyte chemotactic protein-1 excretion in autosomal-dominant polycystic kidney diseaseJared J Grantham, Arlene B Chapman, Jaime Blais, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 15, 2017
Fibroblast Growth Factor 23 and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney DiseaseMichel Chonchol, Berenice Gitomer, Tamara Isakova, et al.
Nature Plants|October 11, 2017
An even pattern of xylan substitution is critical for interaction with cellulose in plant cell wallsNicholas J Grantham, Joel Wurman-Rodrich, Oliver M Terrett, et al.
Journal of the American Society of Nephrology : JASN|February 3, 2006
Comparison of methods for determining renal function decline in early autosomal dominant polycystic kidney disease: the consortium of radiologic imaging studies of polycystic kidney disease cohortAndrew D Rule, Vicente E Torres, Arlene B Chapman, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 22, 2011
Rationale and design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and its Outcomes) 3-4 StudyVicente E Torres, Esther Meijer, Kyongtae T Bae, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 23, 2013
Segmentation of individual renal cysts from MR images in patients with autosomal dominant polycystic kidney diseaseKyungsoo Bae, Bumwoo Park, Hongliang Sun, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 29, 2005
Sonographic assessment of the severity and progression of autosomal dominant polycystic kidney disease: the Consortium of Renal Imaging Studies in Polycystic Kidney Disease (CRISP)W Charles O'Neill, Michelle L Robbin, Kyongtae T Bae, et al.
Kidney International|April 2, 2015
A comparison of ultrasound and magnetic resonance imaging shows that kidney length predicts chronic kidney disease in autosomal dominant polycystic kidney diseaseHarpreet Bhutani, Vikram Smith, Frederic Rahbari-Oskoui, et al.
Pageof 23

Showing results (191-200 of 230) with videos related to

Sort By:
Pageof 23
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 19, 2015
Albuminuria and tolvaptan in autosomal-dominant polycystic kidney disease: results of the TEMPO 3:4 TrialRon T Gansevoort, Esther Meijer, Arlene B Chapman, et al.
Environmental Science & Technology|March 5, 2010
Feather lead concentrations and (207)Pb/(206)Pb ratios reveal lead exposure history of California Condors (Gymnogyps californianus)M E Finkelstein, D George, S Scherbinski, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 19, 2016
Tolvaptan suppresses monocyte chemotactic protein-1 excretion in autosomal-dominant polycystic kidney diseaseJared J Grantham, Arlene B Chapman, Jaime Blais, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 15, 2017
Fibroblast Growth Factor 23 and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney DiseaseMichel Chonchol, Berenice Gitomer, Tamara Isakova, et al.
Nature Plants|October 11, 2017
An even pattern of xylan substitution is critical for interaction with cellulose in plant cell wallsNicholas J Grantham, Joel Wurman-Rodrich, Oliver M Terrett, et al.
Journal of the American Society of Nephrology : JASN|February 3, 2006
Comparison of methods for determining renal function decline in early autosomal dominant polycystic kidney disease: the consortium of radiologic imaging studies of polycystic kidney disease cohortAndrew D Rule, Vicente E Torres, Arlene B Chapman, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 22, 2011
Rationale and design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and its Outcomes) 3-4 StudyVicente E Torres, Esther Meijer, Kyongtae T Bae, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 23, 2013
Segmentation of individual renal cysts from MR images in patients with autosomal dominant polycystic kidney diseaseKyungsoo Bae, Bumwoo Park, Hongliang Sun, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 29, 2005
Sonographic assessment of the severity and progression of autosomal dominant polycystic kidney disease: the Consortium of Renal Imaging Studies in Polycystic Kidney Disease (CRISP)W Charles O'Neill, Michelle L Robbin, Kyongtae T Bae, et al.
Kidney International|April 2, 2015
A comparison of ultrasound and magnetic resonance imaging shows that kidney length predicts chronic kidney disease in autosomal dominant polycystic kidney diseaseHarpreet Bhutani, Vikram Smith, Frederic Rahbari-Oskoui, et al.
Pageof 23